FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, particularly to ophthalmology and clinical pharmacy, and is applicable for visual organ and facial skin sanitation in purulent conjunctivitis, eyelid adhesion and dacryolith formation. The invention consists in the fact that an agent represents an antiseptic water solution consisting of 0.55-1.0 % hydrogen peroxide, 1.0-1.5 % sodium hydrocarbonate and 0.5-1.0 % lidocaine hydrochloride.
EFFECT: invention provides effective and safe conditions for the conjunctival cavity, eyelash, eyelid, surrounding face sanitation.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ESTIMATING LOCAL DRUG TOXICITY | 2008 |
|
RU2396562C1 |
VETERINARY HYGIENIC EYE LOTION | 2022 |
|
RU2785343C1 |
METHOD FOR VIRAL KERATOCONJUNCTIVITIS AGGRAVATED WITH IMMUNOGLOBULIN A DEFICIENCY | 1997 |
|
RU2149610C1 |
MEANS FOR INTRAVITAL SKIN WHITENING NEAR BLUE EYES | 2017 |
|
RU2639485C1 |
METHOD FOR EYES PROTECTION FORM DAMAGING ACTION OF TEAR AGENTS | 2004 |
|
RU2275903C1 |
METHOD FOR TREATING CHLAMYDEOUS CONJUNCTIVITIS | 2000 |
|
RU2187305C2 |
METHOD FOR TREATMENT OF ACUTE NONSPECIFIC CATARRHAL CONJUNCTIVITIS | 2003 |
|
RU2254864C1 |
ANTI-INFLAMMATORY AGENT FOR TREATMENT OF DIFFUSE CATARRHAL KERATITIS AND CATARRHAL CONJUNCTIVITIS IN VETERINARY MEDICINE | 2023 |
|
RU2808893C1 |
METHOD FOR CHOOSING PATHOGENETICALLY CAUSED THERAPEUTIC APPROACH TO VIRAL OCULAR DISEASES | 2012 |
|
RU2494741C1 |
METHOD OF TREATING BLEPHAROCONJUNCTIVAL FORM OF DRY EYE SYNDROME | 2012 |
|
RU2510701C1 |
Authors
Dates
2012-06-10—Published
2011-02-21—Filed